Ranbaxy launches Valaciclovir tablets in US – 27th Nov 09
2009 November 27
Ranbaxy launches Valaciclovir tablets in US; Valtrex has annual sales of over $ 2 Bn in US; Analysts estimate sales worth 0 m for Ranbaxy during exclusivity period: PharmAsiaNews
Ranbaxy launches Valaciclovir tablets in US reports CNBC TV18 quoting PharmAsiaNews.com. Valaciclovir is branded as Valtrex by GSK. Valtrex has annual sales of over $ 2 Bn in US. Analysts estimate sales worth 0 m for Ranbaxy during exclusivity period. Ranbaxy has ‘First To File’ status for Valaciclovir.
Also Read : New Mutual Fund Offers
No related posts.